Delivery Order SPE2DB24D8001-SPE2DB24FKZAU

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $13,879.12 firm fixed-price delivery order is for the supply of 100 units of CONCERTA ER 18 MG TABLET, a prescription medication. The contract has an ultimate completion date of March 11, 2025. Dakota Drug, Inc. is an established federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,600.58, is for the delivery of 100 units of CONCERTA ER 54 MG TABLET. This is a Firm Fixed Price delivery order contract with an ultimate completion date of April 3, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. government, particularly the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,797.75, is a firm fixed-price delivery order without a set-aside designation. It covers the supply of 4,564,879,318 units of CONCERTA ER 36 MG TABLET 100S, a prescription medication, to support the medical supply chain operations for the U.S. Armed...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Concerta ER 54 mg tablets. The contract, valued at $3,485.12, has a firm fixed-price delivery order type and an ultimate completion date of October 17, 2024. This award is not associated with any set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $12,991.31 firm fixed price contract is for the delivery of 100 units of the prescription medication Concerta ER 54 mg tablets. The contract does not have a set-aside designation. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $5,384.21 firm fixed-price delivery order is for the supply of 4568234805 - CONCERTA ER 18 MG TABLET 100S, with a completion date of May 14, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V...
This federal contract award, valued at $5,702.38, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of CONCERTA ER 27 MG TABLET 100S, a prescription medication. This award is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $23,774.87 Firm Fixed Price delivery order contract is for the delivery of 4562940892 CONCERTA ER 27 MG TABLET 100S. The award is not associated with a set-aside program and has an ultimate completion date of November 30, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00 single-award Indefinite Delivery Contract...
This federal contract award, valued at $5,353.16, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order (SPE2DB25FJTSA) under the larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
This federal contract award is for the delivery of Concerta ER 27 mg tablets (100s) to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,084.37 firm-fixed-price delivery order was awarded to Dakota Drug, Inc., a small disadvantaged business, on August 14, 2024 with a completion date of August 15, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB24FKZAU
    Delivery Order

This federal contract award to Dakota Drug, Inc. is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $12,427.91. The contract is for the delivery of Concerta ER 27 mg tablets, and is structured as a firm fixed-price agreement without any set-aside designation.

Dakota Drug, Inc. is the prime contractor for this award, and is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The company specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, primarily the Department of Defense. This contract is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a comprehensive range of medical items to support U.S. Armed Forces medical operations under the DLA Troop Support Medical's ECAT Generation V Program.

Generated 12/13/24, 9:36 AM